Changeflow GovPing Pharma & Drug Safety EPO Patent: Synthesis of 1-Butanol from Carbon ...
Routine Notice Added Final

EPO Patent: Synthesis of 1-Butanol from Carbon Dioxide by Engineered Bacteria

Favicon for changeflow.com ChangeBridge: EPO Bulletin - Biotech (C12N)
Published March 18th, 2026
Detected March 24th, 2026
Email

Summary

The European Patent Office has published a patent application (EP2026030726A1) detailing the synthesis of 1-butanol from carbon dioxide using engineered bacteria. The patent application was published on March 18, 2026, and lists designated states across Europe.

What changed

This document is a patent publication from the European Patent Office (EPO) concerning a method for synthesizing 1-butanol from carbon dioxide using engineered hydrogen bacteria. The patent application number is EP2026030726A1, and it was published on March 18, 2026. The application lists several European countries as designated states where patent protection is sought.

As this is a patent publication, it does not impose direct regulatory obligations or compliance deadlines on regulated entities. However, it signifies potential technological advancements in the field of biotechnology and sustainable chemical production. Companies operating in the chemical manufacturing or biotechnology sectors may wish to monitor this patent for potential licensing opportunities or competitive intelligence.

Source document (simplified)

← EPO Patent Bulletin

SYNTHESIS OF 1-BUTANOL FROM CARBON DIOXIDE BY ENGINEERED HYDROGEN BACTERIA

Publication EP2026030726A1 Kind: A1 Mar 18, 2026

Inventors

The designation of the inventor has not yet been filed

IPC Classifications

C12P 7/16 20060101AFI20260208BHEP C40B 40/02 20060101ALI20260208BHEP C07C 31/12 20060101ALI20260208BHEP C07K 14/195 20060101ALI20260208BHEP C12N 1/20 20260101ALI20260208BHEP C12N 15/01 20060101ALI20260208BHEP

Designated States

AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, ME, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR

View original document →

Source

Analysis generated by AI. Source diff and links are from the original.

Classification

Agency
EPO
Published
March 18th, 2026
Instrument
Notice
Legal weight
Non-binding
Stage
Final
Change scope
Minor
Document ID
EP2026030726A1

Who this affects

Applies to
Drug manufacturers Manufacturers
Industry sector
3254 Pharmaceutical Manufacturing 3241 Chemical Manufacturing
Activity scope
Chemical Synthesis Biotechnology Research
Geographic scope
European Union EU

Taxonomy

Primary area
Pharmaceuticals
Operational domain
Research & Development
Topics
Biotechnology Environmental Technology

Get Pharma & Drug Safety alerts

Weekly digest. AI-summarized, no noise.

Free. Unsubscribe anytime.

Get alerts for this source

We'll email you when ChangeBridge: EPO Bulletin - Biotech (C12N) publishes new changes.

Free. Unsubscribe anytime.